Marshall D. Sklar

1.3k total citations
18 papers, 1.1k citations indexed

About

Marshall D. Sklar is a scholar working on Molecular Biology, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marshall D. Sklar has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marshall D. Sklar's work include Virus-based gene therapy research (4 papers), Neuroblastoma Research and Treatments (4 papers) and Cell death mechanisms and regulation (3 papers). Marshall D. Sklar is often cited by papers focused on Virus-based gene therapy research (4 papers), Neuroblastoma Research and Treatments (4 papers) and Cell death mechanisms and regulation (3 papers). Marshall D. Sklar collaborates with scholars based in United States. Marshall D. Sklar's co-authors include Michael Potter, Wallace P. Rowe, Edward V. Prochownik, Paul A. Singer, W. S. G. Walker, Ben D.‐M. Chen, Allan Tereba, Ethan M. Shevach, Ira Green and Beverly J. White and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Marshall D. Sklar

18 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Marshall D. Sklar 615 398 236 206 167 18 1.1k
Suzanne C. Amsbaugh 710 1.2× 597 1.5× 135 0.6× 208 1.0× 338 2.0× 19 1.3k
Sabine Schirm 891 1.4× 452 1.1× 161 0.7× 196 1.0× 63 0.4× 27 1.5k
Christopher Moulding 1.1k 1.7× 361 0.9× 345 1.5× 312 1.5× 159 1.0× 8 1.7k
H D Royer 998 1.6× 357 0.9× 482 2.0× 166 0.8× 163 1.0× 19 1.6k
L M Neckers 940 1.5× 672 1.7× 523 2.2× 103 0.5× 138 0.8× 24 1.8k
Y Tsujimoto 944 1.5× 400 1.0× 324 1.4× 107 0.5× 103 0.6× 8 1.5k
Roberta K. Reynolds 1.0k 1.6× 431 1.1× 240 1.0× 570 2.8× 137 0.8× 16 1.7k
John A. Feild 905 1.5× 405 1.0× 181 0.8× 341 1.7× 113 0.7× 24 1.5k
M Shearer 782 1.3× 660 1.7× 530 2.2× 222 1.1× 167 1.0× 27 1.6k
A F Gazdar 707 1.1× 573 1.4× 302 1.3× 129 0.6× 76 0.5× 20 1.6k

Countries citing papers authored by Marshall D. Sklar

Since Specialization
Citations

This map shows the geographic impact of Marshall D. Sklar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall D. Sklar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall D. Sklar more than expected).

Fields of papers citing papers by Marshall D. Sklar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marshall D. Sklar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall D. Sklar. The network helps show where Marshall D. Sklar may publish in the future.

Co-authorship network of co-authors of Marshall D. Sklar

This figure shows the co-authorship network connecting the top 25 collaborators of Marshall D. Sklar. A scholar is included among the top collaborators of Marshall D. Sklar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall D. Sklar. Marshall D. Sklar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shumaker, Dale K., Marshall D. Sklar, Edward V. Prochownik, & James Varani. (1994). Increased Cell-Substrate Adhesion Accompanies Conditional Reversion to the Normal Phenotype in Ras-Oncogene-Transformed NIH-3T3 Cells. Experimental Cell Research. 214(2). 440–446. 5 indexed citations
2.
Snyder, Michael E., et al.. (1992). Concomitant Esophageal and Penile Ulcerations Healed with Steroid Therapy in a Patient with AIDS: Case Report. Clinical Infectious Diseases. 15(5). 861–862. 4 indexed citations
3.
Houdek, Pavel V., James G. Schwade, Xiaodong Wu, et al.. (1992). Dose determination in high dose-rate brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 24(4). 795–801. 18 indexed citations
4.
Sklar, Marshall D., Elizabeth L. Thompson, Michael J. Welsh, et al.. (1991). Depletion of c- myc with Specific Antisense Sequences Reverses the Transformed Phenotype in ras Oncogene-Transformed NIH 3T3 Cells. Molecular and Cellular Biology. 11(7). 3699–3710. 16 indexed citations
5.
Sklar, Marshall D., Elizabeth L. Thompson, Michael J. Welsh, et al.. (1991). Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.. Molecular and Cellular Biology. 11(7). 3699–3710. 53 indexed citations
6.
Sklar, Marshall D. & Edward V. Prochownik. (1991). Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc.. PubMed. 51(8). 2118–23. 73 indexed citations
7.
Sklar, Marshall D.. (1988). The ras Oncogenes Increase the Intrinsic Resistance of NIH 3T3 Cells to Ionizing Radiation. Science. 239(4840). 645–647. 309 indexed citations
8.
Sklar, Marshall D.. (1988). Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes.. PubMed. 48(4). 793–7. 134 indexed citations
9.
Sklar, Marshall D., et al.. (1986). Activated oncogenes can substantially alter the radiation response of mouse cells. International Journal of Radiation Oncology*Biology*Physics. 12. 190–191. 4 indexed citations
10.
Sklar, Marshall D., Allan Tereba, Ben D.‐M. Chen, & W. S. G. Walker. (1985). Transformation of mouse bone marrow cells by transfection with a human oncogene related to c‐myc is associated with the endogenous production of macrophage colony stimulating factor 1. Journal of Cellular Physiology. 125(3). 403–412. 79 indexed citations
11.
Sklar, Marshall D. & Geoffrey R. Kitchingman. (1985). Isolation of activated ras transforming genes from two patients with Hodgkin's disease. International Journal of Radiation Oncology*Biology*Physics. 11(1). 49–55. 22 indexed citations
12.
Pui, Ching‐Hon, Judith A. Wilimas, Elizabeth Thompson, et al.. (1983). Hydrocele formation in patients with Hodgkin's disease. Cancer. 51(12). 2301–2303. 4 indexed citations
13.
Sklar, Marshall D., Ethan M. Shevach, Ira Green, & Michael Potter. (1975). Transplantation and preliminary characterisation of lymphocyte surface markers of Abelson virus-induced lymphomas. Nature. 253(5492). 550–552. 62 indexed citations
14.
Raschke, William C., P Ralph, J D Watson, Marshall D. Sklar, & Helen Coon. (1975). Brief Communication: Oncogenic Transformation of Murine Lymphoid Cells by In Vitro Infection With Abelson Leukemia Virus2. JNCI Journal of the National Cancer Institute. 54(5). 1249–1253. 53 indexed citations
15.
Potter, Michael, et al.. (1975). Synthesis, surface deposition, and secretion of immunoglobulins by abelson virus-transformed lymphosarcoma cell lines. Cell. 6(2). 149–159. 89 indexed citations
16.
Sklar, Marshall D., Beverly J. White, & Wallace P. Rowe. (1974). Initiation of Oncogenic Transformation of Mouse Lymphocytes In Vitro by Abelson Leukemia Virus. Proceedings of the National Academy of Sciences. 71(10). 4077–4081. 33 indexed citations
17.
Potter, Michael, Marshall D. Sklar, & Wallace P. Rowe. (1973). Rapid Viral Induction of Plasmacytomas in Pristane-Primed BALB/c Mice. Science. 182(4112). 592–594. 158 indexed citations
18.
Piggot, P. J., Marshall D. Sklar, & Luigi Gorini. (1972). Ribosomal Alterations Controlling Alkaline Phosphatase Isozymes in Escherichia coli. Journal of Bacteriology. 110(1). 291–299. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026